KLK3 and prostate carcinoma: Park YH et al., in their study, showed that the risk of prostate cancer was higher in men with a fluctuating PSA level and PSAV ≥ 1.0 ng/mL/yr than in those with a fluctuating PSA level and PSAV < 1.0 ng/mL/yr [37].